Last edition
News about "paroxysmal supraventricular tachycardia"
3 NODE - 302 data provided by Milestone Pharma
Milestone Pharma presents data from phase 3 NODE-302 study of etripamil to treat paroxysmal supraventricular tachycardia
Paroxysmal Supraventricular Tachycardia | 03/05/2022 | By Sudeep Soparkar | 587
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members